This blog highlights research and development of new treatments, outcomes of global clinical trials and their regulations, with a special focus on ophthalmology and retinal diseases, including drugs and devices. The blog is meant for both clinical and pharmaceutical experts, as well as for patients / family members who are looking for information.
A new analysis published in The Lancet Diabetes and Endocrinology indicates researchers were able to distinguish 5 new subgroups of patients with adult-onset diabetes, representing a first step toward precision medicine for the roughly 415 million patients with the chronic condition.
